US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
AMEX
OS Therapies Incorporated (OSTX)
OS Therapies Incorporated (OSTX) ニュース

OSTX

OS Therapies (OSTX)

OS Therapies Incorporated

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:OSTX

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/16	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:OSTX	OS Therapies Incorporated
2024/11/15	23 : 47	Business Wire	OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update	AMEX:OSTX	OS Therapies Incorporated
2024/11/15	23 : 14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:OSTX	OS Therapies Incorporated
2024/11/15	06 : 58	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	AMEX:OSTX	OS Therapies Incorporated
2024/11/04	21 : 00	Business Wire	OS Therapies to Present at The Spartan Capital Investor Conference	AMEX:OSTX	OS Therapies Incorporated
2024/11/02	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:OSTX	OS Therapies Incorporated
2024/10/30	21 : 51	Business Wire	Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30	AMEX:OSTX	OS Therapies Incorporated
2024/10/30	05 : 10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
2024/10/29	05 : 55	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:OSTX	OS Therapies Incorporated
2024/10/29	05 : 44	Business Wire	OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors	AMEX:OSTX	OS Therapies Incorporated
2024/10/24	21 : 46	Business Wire	OS Therapies to Present at the LD Micro Main Event XVII	AMEX:OSTX	OS Therapies Incorporated
2024/10/17	22 : 22	Business Wire	OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit	AMEX:OSTX	OS Therapies Incorporated
2024/10/03	21 : 00	Business Wire	OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit	AMEX:OSTX	OS Therapies Incorporated
2024/09/13	21 : 09	Business Wire	OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates	AMEX:OSTX	OS Therapies Incorporated
2024/09/05	21 : 22	Business Wire	OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference	AMEX:OSTX	OS Therapies Incorporated
2024/08/29	20 : 53	Business Wire	OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose	AMEX:OSTX	OS Therapies Incorporated
2024/08/22	21 : 00	Business Wire	OS Therapies Appoints Borys Shor, PhD to ADC Advisory Board	AMEX:OSTX	OS Therapies Incorporated
2024/08/22	19 : 00	Business Wire	OS Therapies Clarifies CUSIP of Common Stock	AMEX:OSTX	OS Therapies Incorporated
2024/08/19	21 : 30	Business Wire	OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS	AMEX:OSTX	OS Therapies Incorporated
2024/08/02	21 : 55	Business Wire	OS Therapies Forms Osteosarcoma Patient Advocacy Advisory Board	AMEX:OSTX	OS Therapies Incorporated
2024/08/01	22 : 19	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
2024/08/01	22 : 16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
2024/08/01	22 : 11	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
2024/08/01	22 : 10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
2024/08/01	22 : 08	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:OSTX	OS Therapies Incorporated
2024/08/01	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:OSTX	OS Therapies Incorporated
2024/08/01	07 : 21	Business Wire	OS Therapies Announces Pricing of its Initial Public Offering on NYSE American - Company to Trade under Symbol “OSTX”	AMEX:OSTX	OS Therapies Incorporated
2024/07/31	03 : 41	Edgar (US Regulatory)	Form CERT - Certification by an exchange approving securities for listing	AMEX:OSTX	OS Therapies Incorporated
2024/07/31	03 : 29	Edgar (US Regulatory)	Form 8-A12B - Registration of securities [Section 12(b)]	AMEX:OSTX	OS Therapies Incorporated
2024/07/24	23 : 48	Business Wire	OS Therapies Announces Positive Safety Data from Phase 1 Clinical Trial of OST-HER2 in HER2-Expressing Breast Cancer and in Preclinical Efficacy in Models of Breast Cancer	AMEX:OSTX	OS Therapies Incorporated

Showing the most relevant articles for your search:AMEX:OSTX

Energy Select Sector SPDR

American Express

Bank of America

Invesco QQQ Trust Series 1

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約